This content is restricted.
Brief
On February 24, 2023, the Brazilian National Health Surveillance Agency (Anvisa) published a document titled "Reflexões & Perspectivas: Regulação, Pesquisa Clínica e Inovação". This initiative aims to strengthen the clinical research ecosystem in Brazil and promote innovation in the healthcare sector. The document outlines strategies and guidelines for revising and modernizing regulatory frameworks, simplifying biosimilar regulations, and developing partnerships to enhance national capabilities in conducting clinical research.
Highlights content goes here...
This content is restricted.
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
